Dioscin alleviates aplastic anemia through regulatory T cells promotion

References

• Young NS, Scheinberg P, Calado RT. Aplastic anemia. Curr Opin Hematol. 2008;15(3):162–168. doi:10.1097/MOH.0b013e3282fa7470
   PubMed Web of Science ®Google Scholar
• Park YB, Lee JW, Cho BS, et al. Incidence and etiology of overt gastrointestinal bleeding in adult patients with aplastic anemia. Dig Dis Sci. 2010;55(1):73–81. doi:10.1007/s10620-008-0702-3
   PubMed Web of Science ®Google Scholar
• Dezern AE, Brodsky RA. Clinical management of aplastic anemia. Expert Rev Hematol. 2011;4(2):221–230. doi:10.1586/ehm.11.11
   PubMed Web of Science ®Google Scholar
• Chen FF, Guo ZW, Zhang LN, et al. The change of quality of life in 52 patients with non-severe aplastic anemia after cyclosporine A therapy]. Zhonghua Xue Ye Xue Za Zhi. 2020;41(10):806–810. doi:10.3760/cma.j.issn.0253-2727.2020.10.003
   PubMedGoogle Scholar
• Sloand E, Kim S, Maciejewski JP, et al. Intracellular interferon-γ in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia. Blood. 2002;100(4):1185–1191. doi:10.1182/blood-2002-01-0035
   PubMed Web of Science ®Google Scholar
• Schlöder J, Shahneh F, Schneider FJ, et al. Boosting regulatory T cell function for the treatment of autoimmune diseases - That's only half the battle!. Front Immunol. 2022;13:973813. doi:10.3389/fimmu.2022.973813
   PubMed Web of Science ®Google Scholar
• Shi J, Ge M, Lu S, et al. Intrinsic impairment of CD4+CD25+ regulatory T cells in acquired aplastic anemia. Blood. 2012;120(8):1624–1632. doi:10.1182/blood-2011-11-390708
   PubMed Web of Science ®Google Scholar
• Solomou EE, Rezvani K, Mielke S, et al. Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia. Blood. 2007;110(5):1603–1606. doi:10.1182/blood-2007-01-066258
   PubMed Web of Science ®Google Scholar
• Chen X, Du Y, Lin X, et al. CD4 + CD25 + regulatory T cells in tumor immunity. Int Immunopharmacol. 2016;34:244–249. doi:10.1016/j.intimp.2016.03.009
   PubMed Web of Science ®Google Scholar
• Thompson CB, Allison JP. The emerging role of CTLA-4 as an immune attenuator. Immunity. 1997;7(4):445–450. doi:10.1016/S1074-7613(00)80366-0
   PubMed Web of Science ®Google Scholar
• Clouthier DL, Watts TH. Cell-specific and context-dependent effects of GITR in cancer, autoimmunity, and infection. Cytokine Growth Factor Rev. 2014;25(2):91–106. doi:10.1016/j.cytogfr.2013.12.003
   PubMed Web of Science ®Google Scholar
• Esparza EM, Arch RH. Glucocorticoid-Induced TNF receptor functions as a costimulatory receptor that promotes survival in early phases of T cell activation. J Immunol. 2005;174(12):7869–7874. doi:10.4049/jimmunol.174.12.7869
   PubMed Web of Science ®Google Scholar
• Moesta AK, Li XY, Smyth MJ. Targeting CD39 in cancer. Nat Rev Immunol. 2020;20(12):739–755. doi:10.1038/s41577-020-0376-4
   PubMed Web of Science ®Google Scholar
• Schuler PJ, Saze Z, Hong CS, et al. Human CD4+CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells. Clin Exp Immunol. 2014;177(2):531–543. doi:10.1111/cei.12354
   PubMed Web of Science ®Google Scholar
• Yao H, Tao X, Xu L, et al. Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1/AMPK signaling pathway. Pharmacol Res. 2018;131:51–60. doi:10.1016/j.phrs.2018.03.017
   PubMed Web of Science ®Google Scholar
• Li Y, Gao M, Yin LH, et al. Dioscin ameliorates methotrexate-induced liver and kidney damages via adjusting miRNA-145-5p-mediated oxidative stress. Free Radic Biol Med. 2021;169:99–109. doi:10.1016/j.freeradbiomed.2021.03.035
   PubMed Web of Science ®Google Scholar
• Wu MM, Wang QM, Huang BY, et al. Dioscin ameliorates murine ulcerative colitis by regulating macrophage polarization. Pharmacol Res. 2021;172:105796. doi:10.1016/j.phrs.2021.105796
   PubMed Web of Science ®Google Scholar
• Mao Z, Han X, Chen D, et al. Potent effects of dioscin against hepatocellular carcinoma through regulating TP53-induced glycolysis and apoptosis regulator (TIGAR)-mediated apoptosis, autophagy, and DNA damage. Br J Pharmacol. 2019;176(7):919–937. doi:10.1111/bph.14594
   PubMed Web of Science ®Google Scholar
• Kong C, Lyu D, He C, et al. Dioscin elevates lncRNA MANTIS in therapeutic angiogenesis for heart diseases. Aging Cell. 2021;20(7):e13392. doi:10.1111/acel.13392
   PubMed Web of Science ®Google Scholar
• Wang Y, Yan T, Ma L, et al. Effects of the total saponins from Dioscorea nipponica on immunoregulation in aplastic anemia mice. Am J Chin Med. 2015;43(2):289–303. doi:10.1142/S0192415X15500196
   PubMed Web of Science ®Google Scholar
• Ni R, Fan L, Zhang L, et al. A mouse model of irradiation and spleen-thymus lymphocyte infusion induced aplastic anemia. Hematology. 2022;27(1):932–945. doi:10.1080/16078454.2022.2113356
   PubMed Web of Science ®Google Scholar
• Giudice V, Selleri C. Aplastic anemia: pathophysiology[J]. Semin Hematol. 2022;59(1):13–20. doi:10.1053/j.seminhematol.2021.12.002
   PubMed Web of Science ®Google Scholar
• Wang X, Sun B, Wang Y, et al. Research progress of targeted therapy regulating Th17/Treg balance in bone immune diseases. Front Immunol. 2024;15:1333993. doi:10.3389/fimmu.2024.1333993
   PubMed Web of Science ®Google Scholar
• Zhang L, Ni R, Li J, et al. Dioscin regulating bone marrow apoptosis in aplastic anemia. Drug Des Devel Ther. 2022;16:3041–3053. doi:10.2147/DDDT.S370506
   PubMed Web of Science ®Google Scholar
• Lu LF, Rudensky A. Molecular orchestration of differentiation and function of regulatory T cells. Genes Dev. 2009;23(11):1270–1282. doi:10.1101/gad.1791009
   PubMed Web of Science ®Google Scholar
• Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med. 2006;203(7):1693–1700. doi:10.1084/jem.20060468
   PubMed Web of Science ®Google Scholar
• Lourenço JD, Ito JT, Martins MA, et al. Th17/treg imbalance in chronic obstructive pulmonary disease: clinical and experimental evidence: Clinical and Experimental Evidence. Front Immunol. 2021;12:804919. doi:10.3389/fimmu.2021.804919
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Kawakami R, Mikami N. Treg-based immunotherapy for antigen-specific immune suppression and stable tolerance induction: a perspective. Immunother Adv. 2023;3(1):ltad007. doi:10.1093/immadv/ltad007
   PubMedGoogle Scholar
• Yongjun C, Nan Q, Yumeng S, et al. Dioscin alleviates hashimoto's thyroiditis by regulating the SUMOylation of IRF4 to promote CD4(+)CD25(+)Foxp3(+) treg Cell Differentiation. Autoimmunity. 2021;54(1):51–59. doi:10.1080/08916934.2020.1855428
   PubMed Web of Science ®Google Scholar